共 71 条
[51]
Rock C.L., Michael C.W., Reynolds R.K., Ruffin M.T., Prevention of cervix cancer, Crit Rev Oncol Hematol, 33, pp. 169-185, (2000)
[52]
Schiller J.T., Papillomavirus-like particle vaccines for cervical cancer, Mol Med Today, 5, pp. 209-215, (1999)
[53]
Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., Chiacchierini L.M., Jansen K.U., A controlled trial of a human papillomavirus type 16 vaccine, N Engl J Med, 347, pp. 1645-1651, (2002)
[54]
Nanda K., McCrory D.C., Myers E.R., Bastian L.A., Hasselblad V., Hickey J.D., Matchar D.B., Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review, Ann Intern Med, 132, pp. 810-819, (2000)
[55]
The Canadian guide to clinical preventive health care. Ottawa: Supply and Services Canada, Health Canada Cat H21-1117/1994E, (1994)
[56]
Miller A.B., Anderson G., Brisson J., Laidlaw J., Le Pitre N., Malcolmson P., Mirwaldt P., Stuart G., Sullivan W., Report of a National Workshop on Screening for Cancer of the Cervix, Can Med Assoc J, 145, pp. 1301-1325, (1991)
[57]
Task Force on Cervical Cancer Screening Programs. Cervical cancer screening programs, Can Med Assoc J, 114, pp. 1003-1033, (1976)
[58]
Berkel J., Proceedings of the second national workshop on cervical cancer screening, Chronic Dis Can, 13, pp. S1-S41, (1992)
[59]
Mills C.J., Workshop report. Cervical cancer: toward the implementation of organized screening, Chronic Dis Can, 14, pp. 110-112, (1993)
[60]
Holowaty P., Miller A.B., Rohan T., To T., Natural history of dysplasia of the uterine cervix, J Natl Cancer Inst, 91, pp. 252-258, (1999)